Overton Dropped as FDA Nominee Amid Mifepristone Pushback And MAHA-Obstruction Claims
Updated
The Trump administration withdrew the nomination of Dr. Heidi Overton to lead the FDA the night before the Senate Health, Education, Labor and Pensions Committee was scheduled to vote on advancing her. A senior administration official told Axios that Overton “lacks the support on the Hill to move forward with her confirmation.” The same official added that the administration needs “to go in a new direction at FDA” and that “everybody fully supports Secretary Kennedy’s vision to Make America Healthy Again and get back to a more populist and common-sense approach to health in America.”
Calley Means, who recently resigned as a senior advisor to Secretary Kennedy, appeared on the Joe Rogan Experience less than two weeks ago to criticize Suzie Wiles as Chief of Staff and her associate Overton as particularly hostile to the MAHA agenda. On the same day the JRE episode with Means was released, Wiles was fired from the administration with Stephen Miller named as the replacement.
Senator Bill Cassidy of Louisiana, who has been critical of Secretary Kennedy, contradicted the administration’s claim. He said they “abandoned a viable confirmation path” for Overton, and that he had been having productive conversations. Cassidy said he believed Overton would be approved by the committee and the Senate as FDA Commissioner. Cassidy said Overton convinced him that she would “follow the science and push back against decisions that put Americans’ health at risk.” Cassidy has been particularly critical of efforts by Kennedy and the administration to roll back vaccine recommendations, including the Hepatitis B vaccine.
Cassidy added, “pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues,” but the administration withdrew the nomination rather than make those commitments.
The FDA is currently conducting a study of Mifepristone, the abortion pill, that is expected to be completed in mid-December, with a final report expected no later than March. That study was initiated by Secretary Kennedy and former FDA Commissioner Marty Makary. Makary was criticized by some pro-life senators for “slow-walking” the review on Mifepristone. The Trump administration has been criticized for not inserting an in-person dispensing requirement for Mifepristone that was removed by President Biden during the COVID-19 pandemic.
Overton is a preventive-medicine physician, the deputy director of the White House Domestic Policy Council, and she formerly worked at the America First Policy Institute. President Trump called her a “rockstar” when he nominated her for the role in August to replace Makary as FDA Commissioner. In September, Senators pressed her on mifepristone and vaccines during her confirmation hearing.
While at the America First Policy Institute, Dr. Overton wrote that Mifepristone was “dangerous to women” and was effectively “chemical abortion on demand.” She celebrated the overturning of Roe v. Wade as a “huge victory for life.” When pressed on the abortion pill during her confirmation hearing, she said she would not “prejudge” the ongoing safety review before it is completed. She received criticism from pro-life Senators for not taking a firm stance against mifepristone while pro-choice Senators treated her previous statements about the pill as disqualifying.
Dr. Overton told the committee that every vaccine currently on the U.S. market is safe and effective according to the FDA. She said the MMR vaccine is “not lethal,” and it is the best tool against the ongoing measles outbreak. Overton had previously stood next to President Trump and Secretary Kennedy at the signing of an executive order in August to reduce the number of recommended childhood doses and to break up combination shots. Senator Cassidy previously said her support of that order was “almost disqualifying.”
On JRE, Means described Wiles as the center of power that prevented the administration from making progress on pesticides, school food, and other issues. Means alleged that Overton helped work with the Department of Justice on legal arguments that led to the Supreme Court ruling that granted Bayer and other pesticide manufacturers liability protection from failure-to-warn claims. Means also claimed that Overton told Makary she couldn’t help him unless he approved the mRNA flu vaccine from Moderna that Means called scientifically unjustified. Trump officials have downplayed the role Overton played in the Supreme Court glyphosate brief.
Semafor reported Tuesday morning that the administration was considering Kansas Senator Roger Marshall as the nominee for FDA Commissioner, but no official statements have been made. Senator Marshall has advocated for reinstating the in-person dispensing requirements for Mifepristone.
Marshall has expressed mixed views on vaccines when he questioned Secretary Kennedy last year. He said he doesn’t see the benefit of the Hepatitis B vaccine when a mother tests negative, she isn’t an IV drug abuser, and she is in a stable, monogamous relationship. Senator Marshall also said he is not anti-vax – he touted the benefits of MMR, DPT, Polio, and Smallpox while stating Operation Warp Speed and the COVID-19 vaccines saved millions of lives.